Autoimmune Hemolytic Anemia
📧 Sign up to get email alerts when something new happens for Autoimmune Hemolytic Anemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: A Clinical Study Evaluating the Safety and Efficacy of GT801 Injection in Adult Patients With Relapsed/Refractory CD19-positive B-cell Hematologic Malignancies and Autoimmune Hemolytic Anemia [EARLY_Phase 1]
A Phase 1 clinical trial evaluating the safety and efficacy of GT801 Injection in adults with relapsed/refractory CD19-positive B-cell hemat…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: UCAR T-cell Therapy Targeting CD19/BCMA in Relapsed/Refractory Autoimmune Hemolytic Anemia [EARLY_Phase 1]
A Phase 1 clinical trial evaluating an allogeneic UCAR T-cell therapy targeting CD19 and BCMA for relapsed/refractory Autoimmune Hemolytic A…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: A Multicenter, Prospective, Randomized Controlled Study Comparing Glucocorticoid Combined With Sirolimus With Monotherapy of Glucocorticoid in the Treatment of Newly Diagnosed Mild Autoimmune Hemolytic Anemia [NA]
Multicenter, prospective randomized trial comparing glucocorticoids plus sirolimus versus glucocorticoid monotherapy for newly diagnosed mil…
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: A Study to Investigate the Efficacy, Safety, and Pharmacokinetics of Oral Rilzabrutinib Compared With Placebo in Participants 18 Years of Age and Older With Warm Autoimmune Hemolytic Anemia [Phase 3]
A Phase 3 trial evaluating the efficacy, safety, and pharmacokinetics of oral rilzabrutinib versus placebo in adults with warm autoimmune he…
-
CLINICAL_TRIALS research · 2026-03-09Clinical Trial Update: Orelabrutinib in the Treatment of Relapsed/Refractory AIHA [Phase 2]
Phase 2 clinical trial evaluating Orelabrutinib for relapsed/refractory autoimmune hemolytic anemia. The study status is Not yet Recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: Research on YTS109 Cell in Patients With Recurrent/Refractory Autoimmune Hemolytic Anemia [Phase 1]
The document provides a clinical trial update for a Phase 1 study of YTS109 cell in recurrent/refractory autoimmune hemolytic anemia, with t…
-
CLINICAL_TRIALS trial_result · 2026-03-02Clinical Trial Update: A Study of YTS109 Cell in Subjects With Relapsed/Refractory Autoimmune Hemolytic Anemia [Phase 1]
Phase 1 study evaluating YTS109 Cells in relapsed/refractory autoimmune hemolytic anemia has completed.
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: UCAR-T Targeting CD19/BCMA in Subjects With Autoantibody-Mediated Autoimmune Benign Hematological Diseases [EARLY_Phase 1]
This entry describes an early-phase UCAR-T trial targeting CD19/BCMA for autoimmune hematologic diseases and notes that recruitment is ongoi…
-
CLINICAL_TRIALS withdrawal · 2026-02-11Clinical Trial Update: PI3K Delta Inhibitor in Relapsed / Refractory Autoimmune Hemolytic Anemia Patients After Receiving Two or More Lines of Therapy [Phase 1]
A Phase 1 study of a PI3K delta inhibitor in relapsed or refractory autoimmune hemolytic anemia after two or more lines of therapy has been …
-
CLINICAL_TRIALS other · 2026-02-09Clinical Trial Update: Immunopathology of Autoimmune Hemolytic Anemia
This entry notes that a clinical trial studying the immunopathology of autoimmune hemolytic anemia has completed.
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: Autologous CD19/BCMA Dual-Target CAR-T for Relapsed/Refractory Autoimmune Diseases [Phase 1]
Phase 1 trial evaluating autologous CD19/BCMA dual-target CAR-T therapy for relapsed/refractory autoimmune diseases; currently recruiting at…
-
CLINICAL_TRIALS other · 2025-12-31Clinical Trial Update: French Registry of Adult Patients With Immune Thrombocytopenia and Autoimmune Hemolytic Anemia
A French registry study enrolling adults with immune thrombocytopenia and autoimmune hemolytic anemia is currently recruiting.
-
CLINICAL_TRIALS research · 2025-12-22Clinical Trial Update: Efficacy of Prolonged Anticoagulation for Primary Prevention of Venous Thromboembolic Disease in Autoimmune Hemolytic Anemia: a Prospective, Phase II, Randomized, Multicenter Study [Phase 2]
Prospective Phase II randomized multicenter trial evaluating prolonged anticoagulation for primary prevention of venous thromboembolism in a…
-
CLINICAL_TRIALS research · 2025-12-17Clinical Trial Update: A Study of YTS109 Cell in Subjects With Relapsed/Refractory Autoimmune Hemolytic Anemia [Phase 1]
Phase 1 trial update for YTS109 cell therapy in relapsed/refractory autoimmune hemolytic anemia; the study is not yet recruiting.
-
CLINICAL_TRIALS research · 2025-12-17Clinical Trial Update: A Study of CM336 in Patients With Relapsed or Refractory Autoimmune Cytopenia [Phase 1, Phase 2]
Clinical trial update for CM336 in relapsed or refractory autoimmune cytopenia, including immune thrombocytopenia, autoimmune hemolytic anem…
-
CLINICAL_TRIALS research · 2025-11-21Clinical Trial Update: Severe Immune Cytopenia Registry Www.Sic-reg.Org
This entry provides a completed update on the Severe Immune Cytopenia Registry (SIC-reg), sponsored by the Medical University of Graz, cover…
-
CLINICAL_TRIALS withdrawal · 2025-11-10Clinical Trial Update: Extension Study (Extended Access) of Syk-inhibition Using Fostamatinib to Treat Posttransplant Immune-mediated Cytopenias [Phase 2]
An extension study of fostamatinib (Syk inhibitor) for posttransplant immune-mediated cytopenias has been withdrawn, including autoimmune he…
-
CLINICAL_TRIALS research · 2025-09-30Clinical Trial Update: OM336 in Autoimmune Cytopenias [Phase 1]
Ouro Medicines reports a Phase 1 clinical trial of OM336 for autoimmune cytopenias, including warm and cold autoimmune hemolytic anemia and …
-
CLINICAL_TRIALS research · 2025-09-24Clinical Trial Update: A Single-arm Phase 2 Prospective Clinical Study of Enatumab in the Treatment of Relapsed/Refractory Warm Antibody Autoimmune Hemolytic Anemia [Phase 2]
Phase 2 single-arm trial of enatumab for relapsed/refractory warm antibody autoimmune hemolytic anemia; not yet recruiting.
-
CLINICAL_TRIALS research · 2025-09-22Clinical Trial Update: Inaticabtagene Autoleucel Injection in the Treatment of Autoimmune Hemolytic Anemia After Three or More Lines of Therapy [Phase 1]
A Phase 1 clinical trial evaluating Inaticabtagene Autoleucel for autoimmune hemolytic anemia after three or more prior therapies; the study…
-
CLINICAL_TRIALS other · 2025-09-17Clinical Trial Update: Safety Study of CC312 in Autoimmune Disease Patients [EARLY_Phase 1]
Early-phase safety study of CC312 in multiple autoimmune diseases is currently recruiting, sponsored by CytoCares Inc.
-
CLINICAL_TRIALS trial_result · 2025-09-11Clinical Trial Update: Safety and Tolerability Study in Adults With Cold Agglutinin Disease Previously Treated With SAR445088 or Never Treated With SAR445088 [Phase 1]
Phase 1 safety and tolerability study of SAR445088 in adults with cold agglutinin disease, previously treated vs untreated, has been termina…
-
CLINICAL_TRIALS research · 2025-09-08Clinical Trial Update: Conception of a Diagnosis, Prognosis and Therapeutic Decision Tool for Patients With Autoimmunity and Inflammation
A recruiting clinical trial in France aims to develop a diagnosis, prognosis, and therapeutic decision-support tool for autoimmune and infla…
-
CLINICAL_TRIALS research · 2025-09-02Clinical Trial Update: A Single-arm Phase 2 Prospective Clinical Study of Linprixel in the Treatment of Relapsed/Refractory Autoimmune Hemolytic Anemia
This clinical trial update outlines a single-arm Phase 2 prospective study evaluating Linprixel for relapsed/refractory autoimmune hemolytic…
-
CLINICAL_TRIALS research · 2025-08-05Clinical Trial Update: Brain Function and Psychological Changes Related to Cell Therapy for Autoimmune Hemolytic Anemia
The study investigates brain function and psychological changes related to CAR T-cell therapy in autoimmune hemolytic anemia, and the trial …